Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Elixiron Immunotherapeutics Inc.

Clinical trials sponsored by Elixiron Immunotherapeutics Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug targets brain inflammation in Alzheimer's Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

New drug EI1071 tested for safety in healthy people

Knowledge-focused Completed

This early-phase trial tested the safety and tolerability of a new drug called EI1071 in 58 healthy volunteers. Participants received either single or multiple doses of the drug or a placebo. The study aimed to understand how the body processes the drug and whether it causes any …

Phase 1 • Sponsor: Elixiron Immunotherapeutics Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 13:04 UTC